Sanofi to sell 51% stake in Opella
Sanofi, CD&R in Exclusive Negotiations for Sale, Purchase of 50% Stake in Opella
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More.
Clayton Dubilier & Rice is nearing a deal to acquire control of Sanofi’s consumer health unit after the American buyout firm ...
Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...
France's CGT and CFDT unions have called on workers at pharma company Sanofi to strike from Thursday to show their protest ...
Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice ...
Analysts at Zacks Research decreased their Q4 2025 earnings estimates for Sanofi in a research note issued on Tuesday, ...
Sanofi on Friday said it’s in talks with the private equity firm CD&R to sell just over half of its consumer healthcare ...
Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...
Sanofi said on Monday it had entered exclusive negotiations for the sale of a 50% controlling stake in its consumer health ...
Deal for consumer health arm has faced a political backlash over ceding controlling stake to American private equity group ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback